Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposingLaura Riva, Sumit K. Chanda, Shuofeng Yuan et al.|Nature|2020Cited by 856
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanomaNoam Auslander, Eytan Ruppin, Gao Zhang et al.|Nature Medicine|2018Cited by 813
UVB-Induced Tumor Heterogeneity Diminishes Immune Response in MelanomaYochai Wolf, Yardena Samuels, Osnat Bartok et al.|Cell|2019Cited by 394
Immunoproteasome expression is associated with better prognosis and response to checkpoint therapies in melanomaShelly Kalaora, Yardena Samuels, Joo Sang Lee et al.|Nature Communications|2020Cited by 156
Evolution of delayed resistance to immunotherapy in a melanoma responderDavid Liu, Genevieve M. Boland, Jia‐Ren Lin et al.|Nature Medicine|2021Cited by 135